|4Nov 22, 5:44 PM ET

Flynn Patrick John 4

4 · NRX Pharmaceuticals, Inc. · Filed Nov 22, 2022

Insider Transaction Report

Form 4
Period: 2022-10-21
Transactions
  • Award

    Employee Stock Option

    2022-10-21+162,660162,660 total
    Exercise: $0.75Exp: 2032-10-21Common Stock (162,660 underlying)
Footnotes (1)
  • [F1]Options issued under the NRx Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan. The options vest on May 25, 2023, generally subject to the Reporting Person's continued service for NRx Pharmaceuticals, Inc.

Documents

1 file
  • 4
    es220307154_4-flynnp.xmlPrimary

    OWNERSHIP DOCUMENT